{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreia2mwshy4xnyf5ms37anq7qinmfm7zkh4urpu5nia55kottdeuvhu",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mgqr4c6k72d2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihmskijefw5yduqnaaey365fdh6p7y45xbkdw4z2k4tzpngdjz6wa"
    },
    "mimeType": "image/jpeg",
    "size": 75166
  },
  "path": "/pharmalot/2026/03/10/drugmakers-develop-fewer-antibiotics-antimicrobials/?utm_campaign=rss",
  "publishedAt": "2026-03-10T10:00:00.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharmalot",
    "antibiotics",
    "biotechnology",
    "Pharmaceuticals",
    "STAT+"
  ],
  "textContent": "The number of potential antimicrobial treatments being developed by the world’s largest drugmakers nosedived by 35% over the past five years, according to a new analysis.",
  "title": "STAT+: Large drugmakers are developing fewer antibiotics, analysis finds",
  "updatedAt": "2026-03-10T12:00:38.000Z"
}